Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
6912 | 1430 | 49.4 | 90% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
159 | 3 | MENOPAUSE//ISOFLAVONES//TAMOXIFEN | 61134 |
329 | 2 | TAMOXIFEN//ESTROGEN RECEPTOR//AROMATASE INHIBITORS | 18133 |
6912 | 1 | ESTROGEN RECEPTOR BETA//ER BETA//RECEPTOR BIOL SECT | 1430 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ESTROGEN RECEPTOR BETA | authKW | 1033168 | 12% | 28% | 176 |
2 | ER BETA | authKW | 345981 | 5% | 23% | 71 |
3 | RECEPTOR BIOL SECT | address | 205901 | 2% | 28% | 35 |
4 | NUCL RECEPTORS CELL SIGNALING | address | 137133 | 3% | 16% | 40 |
5 | ESTROGEN RECEPTOR | authKW | 136724 | 14% | 3% | 207 |
6 | ER BETA ISOFORMS | authKW | 128110 | 0% | 100% | 6 |
7 | ESTROGEN RECEPTOR ALPHA | authKW | 93317 | 4% | 7% | 64 |
8 | ER BETA 1 | authKW | 76861 | 0% | 60% | 6 |
9 | REPROD DEV TOXICOL | address | 76752 | 3% | 8% | 46 |
10 | ER ALPHA | authKW | 73343 | 3% | 8% | 42 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Endocrinology & Metabolism | 10660 | 34% | 0% | 480 |
2 | Oncology | 3594 | 27% | 0% | 387 |
3 | Cell Biology | 1173 | 16% | 0% | 232 |
4 | Biochemistry & Molecular Biology | 845 | 24% | 0% | 337 |
5 | Reproductive Biology | 709 | 5% | 0% | 67 |
6 | Pathology | 203 | 4% | 0% | 58 |
7 | Obstetrics & Gynecology | 151 | 4% | 0% | 56 |
8 | Urology & Nephrology | 133 | 4% | 0% | 51 |
9 | Developmental Biology | 60 | 2% | 0% | 24 |
10 | Andrology | 51 | 0% | 0% | 6 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | RECEPTOR BIOL SECT | 205901 | 2% | 28% | 35 |
2 | NUCL RECEPTORS CELL SIGNALING | 137133 | 3% | 16% | 40 |
3 | REPROD DEV TOXICOL | 76752 | 3% | 8% | 46 |
4 | NOVUM | 70809 | 6% | 4% | 86 |
5 | MED NUTR | 67638 | 4% | 6% | 57 |
6 | MED NUTR BIOSCI | 56927 | 1% | 33% | 8 |
7 | BIOSCI NUTR | 52050 | 5% | 4% | 65 |
8 | REPROD SCI CELLULAR MOL PHARMACOL | 48040 | 0% | 75% | 3 |
9 | UNIT NUCL RECEPTOR BIOL | 42703 | 0% | 100% | 2 |
10 | DIGEST VASC | 42695 | 0% | 33% | 6 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MOLECULAR ENDOCRINOLOGY | 19624 | 5% | 1% | 72 |
2 | JOURNAL OF MOLECULAR ENDOCRINOLOGY | 10423 | 2% | 2% | 32 |
3 | MOLECULAR AND CELLULAR ENDOCRINOLOGY | 5868 | 3% | 1% | 49 |
4 | ENDOCRINE-RELATED CANCER | 5662 | 1% | 1% | 21 |
5 | JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY | 5172 | 3% | 1% | 47 |
6 | ENDOCRINOLOGY | 4139 | 5% | 0% | 70 |
7 | BREAST CANCER RESEARCH AND TREATMENT | 2108 | 2% | 0% | 27 |
8 | PROSTATE | 2038 | 1% | 0% | 21 |
9 | STEROIDS | 1745 | 1% | 0% | 19 |
10 | HORMONES & CANCER | 1329 | 0% | 2% | 3 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ESTROGEN RECEPTOR BETA | 1033168 | 12% | 28% | 176 | Search ESTROGEN+RECEPTOR+BETA | Search ESTROGEN+RECEPTOR+BETA |
2 | ER BETA | 345981 | 5% | 23% | 71 | Search ER+BETA | Search ER+BETA |
3 | ESTROGEN RECEPTOR | 136724 | 14% | 3% | 207 | Search ESTROGEN+RECEPTOR | Search ESTROGEN+RECEPTOR |
4 | ER BETA ISOFORMS | 128110 | 0% | 100% | 6 | Search ER+BETA+ISOFORMS | Search ER+BETA+ISOFORMS |
5 | ESTROGEN RECEPTOR ALPHA | 93317 | 4% | 7% | 64 | Search ESTROGEN+RECEPTOR+ALPHA | Search ESTROGEN+RECEPTOR+ALPHA |
6 | ER BETA 1 | 76861 | 0% | 60% | 6 | Search ER+BETA+1 | Search ER+BETA+1 |
7 | ER ALPHA | 73343 | 3% | 8% | 42 | Search ER+ALPHA | Search ER+ALPHA |
8 | ESTROGEN RECEPTOR BETA 2 | 68324 | 0% | 80% | 4 | Search ESTROGEN+RECEPTOR+BETA+2 | Search ESTROGEN+RECEPTOR+BETA+2 |
9 | ER BETA 2 | 66720 | 0% | 63% | 5 | Search ER+BETA+2 | Search ER+BETA+2 |
10 | ESR2 | 61497 | 1% | 26% | 11 | Search ESR2 | Search ESR2 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | MURPHY, LC , LEYGUE, E , (2012) THE ROLE OF ESTROGEN RECEPTOR-BETA IN BREAST CANCER.SEMINARS IN REPRODUCTIVE MEDICINE. VOL. 30. ISSUE 1. P. 5-13 | 75 | 77% | 32 |
2 | LEUNG, YK , LEE, MT , LAM, HM , TARAPORE, P , HO, SM , (2012) ESTROGEN RECEPTOR-BETA AND BREAST CANCER: TRANSLATING BIOLOGY INTO CLINICAL PRACTICE.STEROIDS. VOL. 77. ISSUE 7. P. 727-737 | 100 | 57% | 22 |
3 | LEYGUE, E , MURPHY, LC , (2013) A BI-FACETED ROLE OF ESTROGEN RECEPTOR BETA IN BREAST CANCER.ENDOCRINE-RELATED CANCER. VOL. 20. ISSUE 3. P. R127 -R139 | 77 | 70% | 19 |
4 | NELSON, AW , GROEN, AJ , MILLER, JL , WARREN, AY , HOLMES, KA , TARULLI, GA , TILLEY, WD , KATZENELLENBOGEN, BS , HAWSE, JR , GNANAPRAGASAM, VJ , ET AL (2017) COMPREHENSIVE ASSESSMENT OF ESTROGEN RECEPTOR BETA ANTIBODIES IN CANCER CELL LINE MODELS AND TISSUE REVEALS CRITICAL LIMITATIONS IN REAGENT SPECIFICITY.MOLECULAR AND CELLULAR ENDOCRINOLOGY. VOL. 440. ISSUE C. P. 138 -150 | 71 | 72% | 0 |
5 | GALLO, D , DE STEFANO, I , PRISCO, MG , SCAMBIA, G , FERRANDINA, G , (2012) ESTROGEN RECEPTOR BETA IN CANCER: AN ATTRACTIVE TARGET FOR THERAPY.CURRENT PHARMACEUTICAL DESIGN. VOL. 18. ISSUE 19. P. 2734 -2757 | 125 | 42% | 20 |
6 | REESE, JM , SUMAN, VJ , SUBRAMANIAM, M , WU, XL , NEGRON, V , GINGERY, A , PITEL, KS , SHAH, SS , CUNLIFFE, HE , MCCULLOUGH, AE , ET AL (2014) ER BETA 1: CHARACTERIZATION, PROGNOSIS, AND EVALUATION OF TREATMENT STRATEGIES IN ER ALPHA-POSITIVE AND -NEGATIVE BREAST CANCER.BMC CANCER. VOL. 14. ISSUE . P. - | 60 | 82% | 10 |
7 | OMOTO, Y , IWASE, H , (2015) CLINICAL SIGNIFICANCE OF ESTROGEN RECEPTOR BETA IN BREAST AND PROSTATE CANCER FROM BIOLOGICAL ASPECTS.CANCER SCIENCE. VOL. 106. ISSUE 4. P. 337 -343 | 53 | 76% | 12 |
8 | HALDOSEN, LA , ZHAO, CY , DAHLMAN-WRIGHT, K , (2014) ESTROGEN RECEPTOR BETA IN BREAST CANCER.MOLECULAR AND CELLULAR ENDOCRINOLOGY. VOL. 382. ISSUE 1. P. 665-672 | 47 | 85% | 25 |
9 | WU, XL , SUBRAMANIAM, M , NEGRON, V , CICEK, M , REYNOLDS, C , LINGLE, WL , GOETZ, MP , INGLE, JN , SPELSBERG, TC , HAWSE, JR , (2012) DEVELOPMENT, CHARACTERIZATION, AND APPLICATIONS OF A NOVEL ESTROGEN RECEPTOR BETA MONOCLONAL ANTIBODY.JOURNAL OF CELLULAR BIOCHEMISTRY. VOL. 113. ISSUE 2. P. 711-723 | 52 | 91% | 15 |
10 | FOX, EM , DAVIS, RJ , SHUPNIK, MA , (2008) ER BETA IN BREAST CANCER - ONLOOKER, PASSIVE PLAYER, OR ACTIVE PROTECTOR?.STEROIDS. VOL. 73. ISSUE 11. P. 1039-1051 | 71 | 61% | 78 |
Classes with closest relation at Level 1 |